top of page

Hop On A Cure Foundation Announces Investment in MitoSense’s MOT™ Technology to Revolutionize ALS Treatment


ATLANTA, Ga. (January 30, 2024) - Nonprofit foundation Hop On A Cure, a leading advocate in the fight against ALS, is proud to announce its substantial investment in MitoSense, an innovative biotechnology firm specializing in mitochondrial therapies. This collaboration marks a significant step in advancing MitoSense's flagship technology, MOT™ (Mitochondria Organelle Transplantation), a promising new approach to ALS treatment.


Hop On A Cure was founded in 2022 by John Driskell Hopkins (Hop), and his wife Jennifer, following his diagnosis  with ALS (commonly known as Lou Gehrig’s Disease) in 2021. Hopkins is a multi-GRAMMY® Award-winning founding member and songwriter of  Zac Brown Band. With this rare platform in mind, Hopkins, along with his wife Jennifer, launched Hop On A Cure to increase ALS awareness and to raise funds to enable new research to find ways to treat this disease, which currently has no known cure.


MOT™, a novel therapeutic concept developed by MitoSense, leverages the unique capabilities of mitochondria to combat the progression of Amyotrophic Lateral Sclerosis (ALS). By directly transplanting healthy mitochondria into affected cells, MOT™ seeks to restore cellular function and slow down, or potentially reverse, the debilitating symptoms of ALS. This approach represents a groundbreaking shift in the battle against this relentless disease, offering hope where traditional treatments have seen limited success.


Van Hipp, Chairman of MitoSense, expressed his enthusiasm about the partnership: "With Hop On A Cure's support, we're poised to take a quantum leap in ALS treatment. MOT™ is not just a treatment; it's a beacon of hope for those affected by ALS. Together, we're charting a course towards a future where ALS is a manageable condition, not a terminal diagnosis."

Nic Shefrin from Hop On A Cure also shared their perspective: "Our investment in MitoSense and the development of MOT™ reflects our unwavering commitment to finding a cure for ALS. We believe that MOT™ holds the key to unlocking new, effective treatments, and we're excited to be part of this revolutionary journey."

 

This strategic investment will accelerate the clinical development of MOT™, bringing it closer to clinical application and potentially changing the ALS treatment landscape forever.


For more information, visit www.mitosenseinc.com.



About Hop On A Cure Foundation

Hop On A Cure started in 2022 after John Driskell Hopkins of Zac Brown Band was diagnosed with ALS. ALS is consistently one of the most underfunded diseases for research. Because of that, not much significant progress has been made since Lou Gehrig passed away from the disease in 1941. The mission of the foundation is to support research to prevent, reverse, and cure ALS while raising awareness, building a compassionate community, and unleashing the healing power of hope. For more information about Hop On A Cure visit www.hoponacure.org.


Comentários


bottom of page